To include your compound in the COVID-19 Resource Center, submit it here.

EY-128: Started a Phase I/II trial

Telor Ophthalmic

Read the full 21 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE